Anadin Soft Capsule 0.5 mg (Dutasteride)

Adult dose

The recommended dose of this medicine is 1 capsule (0.5mg) once daily. Because exposure to the contents of the capsule may cause irritation of the oropharyngeal mucosa, swallow the capsule whole without chewing or breaking it. This medicine may be taken with or without food. No dose adjustment is necessary in patients with renal impairment or elderly patients. The recommended dose of this medicine in patients with hepatic impairment has not been established because there are no data on its administration to such patients.

This medication can be absorbed through the skin, so women who are pregnant or may become pregnant should not handle or take this medication. If the capsule breaks and comes into contact with the skin, the affected area should be washed thoroughly with soap and water immediately. This medication is prohibited for use in children under 18 years of age, and caution should be taken to prevent children from coming into contact with it. This medication should not be administered to patients with specific allergic reactions or to women. Men planning for pregnancy should use this medication cautiously after consulting a physician, as it may affect fertility. Patients with liver dysfunction or severely reduced urinary flow should use this medication with caution and require monitoring by healthcare providers. This medication can interact with other drugs, especially if the patient is taking strong CYP3A4 inhibitors. During the course of taking this medication, side effects related to sexual function such as erectile dysfunction, decreased libido, and ejaculatory disorders may occur, and some side effects may persist even after discontinuation of the medication. During blood tests, prostate-specific antigen (PSA) levels may decrease, so this should be taken into account when interpreting PSA levels. Regular evaluations for prostate cancer and PSA tests are required while taking this medication. Although the frequency of sexual side effects or breast disorders has been reported not to increase with long-term use, any unusual symptoms in the breast should be reported to a physician immediately. Patients taking this medication should refrain from donating blood, and at least 6 months should pass after the last dose before blood donation is allowed. No specific antidote is available for overdose; appropriate treatment should be administered according to symptoms, and long-term monitoring may be necessary due to the long half-life of this medication. It should be stored out of reach of children, and kept in its original container to prevent degradation or misuse. There is a low probability that it will affect the ability to drive or operate machinery. In patients with heart failure, the risk of heart failure may slightly increase when this medication is combined with other drugs, so caution is needed. This medication is contraindicated in women and should not be used in breastfeeding women.

• Erectile dysfunction
• decreased libido
• ejaculation disorder
• gynecomastia
• headache
• gastrointestinal discomfort and pain
• sexual dysfunction
• breast disorders
• dizziness
• rash

This medication should be stored in a tightly closed container to prevent air ingress and in a cool place below 30 degrees Celsius. This will help maintain the medication's efficacy and prevent deterioration.

Appearance

Transparent soft capsule with a pale yellow, transparent oval shape containing a clear substance

Package unit

30 capsules (15 capsules/PTP × 2)